BIIB 241213 162.50P (BIIB241213P162500) Stock Options, News & Quotes

US OptionsDetailed Quotes

BIIB241213P162500

Watchlist

5.15
-0.05-0.96%

15min DelayClose Dec 10 16:00 ET

5.15High5.15Low

Intraday

5D
Daily

News

Biogen Reinstated With a Neutral at BofA
Yahoo Finance36minutes ago
BofA Restarts Coverage of 11 Large-cap Biopharmas
Seeking Alpha17:01 ET
Market Falls Wednesday, but Googles Chip Impresses | WST
Kevin Travers16:19 ET
Google's Quantum Chip Might Have Contacted Parallel Universes | Live Stock
Kevin TraversDec 10 10:51 ET
B of A Securities Reinstates Neutral on Biogen, Announces $178 Price Target
BenzingaDec 10 07:38 ET · Ratings
Insider Sale: Head of Development of $BIIB (BIIB) Sells 110 Shares
Quiver QuantitativeDec 9 17:02 ET

Comments

Moomoo News Global

Dec 4 08:19

Columns Which Stocks Could Join the Nasdaq 100? Palantir and MicroStrategy Lead the List

The annual adjustment of the $NASDAQ 100 Index (.NDX.US)$ components will be announced next Friday (December 13). According to the market capitalization ranking, in addition to the strong performers $Palantir (PLTR.US)$ and $MicroStrategy (MSTR.US)$, $Equinix Inc (EQIX.US)$, and $Coinbase (COIN.US)$ are also expected to become new members.
On the other hand, six companies, headed by $Moderna (MRNA.US)$, $Super Micro Computer (SMCI.US)$, ...

Nasdaq hits new highs, adjustment looms: Who will stand out?

J-Eazy

Nov 15 13:08

garabage

this stock is 🗑️
$Biogen (BIIB.US)$

QMengColdJoke

Nov 14 10:04

? you just saved world?

$Biogen (BIIB.US)$

Movers and Shakers

Oct 30 07:28

Columns Today's Pre-Market Movers and Top Ratings | GOOGL, AMD, V, LLY and More

Morning Movers
Gapping up
$Alphabet-A (GOOGL.US)$ stock rose 6.3% following third-quarter results that exceeded expectations, with a notable increase in advertising revenue, which alleviated concerns over competition from AI-driven search products.
$Biogen (BIIB.US)$ stock increased 1.2% after the biotech company raised its annual earnings forecast and reported third-quarter earnings that surpassed both top and bottom line expe...